Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

ESTIGMA: PERMANÊNCIA CULTURAL DA HANSENÍASE

Rocha G. Revista da Academia de Ciências do Piauí. 2020; 1 (1) : 84-98.
Download PDF
Publication

Exploration Of Renal Function In Leprosy Patients Under Treatment And Those Who Have Undergone Anti-Leprosy Treatment At The OUIDAH Leprosy Treatment Center (BENIN)

Nicolas A, LAPO RA, Amadou CF, et al. British Journal of Medical & Health Sciences. 2020;
Download PDF
Publication

Hanseniasis in the municipality of Western Amazon (Acre, Brazil): are we far from the goal of the World Health Organization?: Hansen and Western Amazon.

Araújo F, Abreu L, Laporta G, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2020;
Download PDF
Publication

Porcentajes variables de casos de lepra paucibacilar en la notificación global de casos de lepra.

Butlin CR, Lockwood DNJ. Revista de Leprología. 2020; 32 (6) : 441-449.
Publication

La influencia del poder colonial sobre la población y la naturaleza determinaron los asentamientos de la enfermedad de Hansen en Surinam.

Menke H, Pieters T, Menke J. Revista de Leprología. 2020; 32 (6) : 411-439.
Publication

Lepra borderline tuberculoide. Presentación de un caso.

González IB, Gutiérrez DF, Díaz Renón MT, et al. Revista de Leprología. 2020; 32 (6) : 395-400.
Publication

Lepra: a propósito de tres casos de presentación atípica.

Gutiérrez LF, Centurión I, Elli M, et al. Revista de Leprología. 2020; 32 (6) : 401-409.
Publication

Consejos sobre lepra y COVID-19.

ILEP . Revista de Leprología. 2020; 32 (6) : 451-453.
Publication

Why do Leprosy patients default treatment; Evidence from Sri Lanka

Arnold M. International Journal of Progressive Sciences and Technologies. 2020; 23 (2) : 654-659.
Download PDF
Publication

Perfil epidemiológico da hanseníase no município de anápolis – goiás entre os anos de 2015 a 2019

Sousa MVDP, Dutra ACF, De Lima GC, et al. Associacao Educativa Evangelica. Revista Educação em Saúde. 2020; 8 (2) : 57-63.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 308
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD